Vascular Ehlers-Danlos syndrome (vEDS) is the most dangerous subtype of the Ehlers-Danlos group of connective tissue disorders, defined by a risk of spontaneous rupture or dissection of arteries, the bowel, and the uterus during pregnancy. It is caused by mutations in the COL3A1 gene, which provides the blueprint for type III collagen, a structural protein that gives strength and elasticity to blood vessel walls and hollow organs.1Matrix Biology Plus. Four decades in the making: Collagen III and mechanisms of vascular Ehlers Danlos Syndrome Because the condition is rare and its outward signs can be subtle, many people go undiagnosed until a life-threatening complication strikes.
What Makes vEDS Different from Other Types of EDS
Ehlers-Danlos syndrome is not a single disease but a family of related conditions. Most types cause joint hypermobility, stretchy skin, and chronic pain. Vascular EDS stands apart because the fragile tissue is not mainly in the joints or skin surface but inside the body, in arterial walls, the intestinal lining, and the uterus. While hypermobile EDS (the most common type) rarely causes organ rupture, vEDS is considered the most severe subtype precisely because its complications can be sudden and fatal.2PubMed Central. Comprehensive review of aortic aneurysms, dissections, and cardiovascular complications in connective tissue disorders
All forms of EDS combined affect somewhere between 1 in 10,000 and 1 in 25,000 people, and vEDS accounts for roughly 5 to 10 percent of those cases. That makes it genuinely rare, which partly explains why emergency physicians and surgeons sometimes miss it.3PubMed Central. Ehlers-Danlos syndrome type IV
How Defective Collagen III Causes the Problem
Type III collagen is one of the main structural proteins in blood vessels and the walls of organs like the colon and uterus. When the COL3A1 gene carries a mutation, the collagen molecules it produces fold incorrectly or are produced in reduced amounts. Because the condition is inherited in an autosomal dominant pattern, a single faulty copy of the gene from one parent is enough to cause disease. The defective collagen chains get woven into the tissue alongside normal ones, weakening the overall structure in a way that goes far beyond just cutting production in half.4PubMed. Natural history of gastrointestinal manifestations in vascular Ehlers-Danlos syndrome: A 17-year retrospective review This “dominant negative” effect means that the mutant protein actively disrupts the tissue, rather than simply leaving a gap where healthy collagen should be.
The practical result is that the walls of arteries, the intestine, and the uterus are structurally unsound from birth, even though they may function normally for years or decades before a complication occurs. Unlike an injury-related aneurysm, which develops at a specific weak spot, the fragility in vEDS is widespread throughout the body’s vascular and hollow-organ tissue.
Recognizing the Physical Signs
People with vEDS sometimes share a recognizable set of facial features: large eyes, a thin nose and lips, a small chin, hollow-looking cheeks, and ears that lack fleshy lobes.5PubMed Central. Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report The skin is often thin and translucent enough to make veins clearly visible, especially on the chest, abdomen, and lower back. Easy and severe bruising, even from minor bumps, is another hallmark.6PubMed. Clinical and genetic features of vascular Ehlers-Danlos syndrome
These features are helpful when they are present, but they do not appear in every patient. A case report in the medical literature describes a patient confirmed to have vEDS through genetic testing who lacked the characteristic facial appearance entirely.7PubMed Central. Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report That variability is part of what makes the condition easy to miss. A young person who shows up in an emergency room with a spontaneous arterial dissection but an unremarkable face may not trigger the suspicion needed for a diagnosis.
Lesser-Known Physical Features That Can Point to a Diagnosis
Beyond the classic facial look and translucent skin, data from the UK’s national diagnostic service in Sheffield identified several underappreciated features in their cohort of vEDS patients:
- Early varicose veins: About 15 percent developed varicose veins before age 30, excluding cases triggered by pregnancy.
- Clubfoot (talipes): Present in 13 percent, often severe enough that physiotherapy alone did not correct it and surgery was required in most cases.
- Finger and tendon contractures: Seen in a smaller fraction, these were progressive and resistant to treatment, affecting the hands, feet, or Achilles tendons.
- Keratoconus: A thinning and bulging of the cornea occurred in about 1 percent of the cohort.
The Sheffield group’s point is that these features, while individually uncommon, could help clinicians think of vEDS earlier when they appear alongside even mild bruising or a family history of unexplained arterial events.8European Journal of Human Genetics. Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield
The Major Complications
The defining dangers of vEDS fall into three categories: arterial, gastrointestinal, and uterine.
Arterial Dissection and Rupture
Arteries throughout the body can dissect (tear along the inner wall) or rupture outright, sometimes without warning. Medium-sized arteries are particularly vulnerable, though the aorta and its major branches are involved as well. A study comparing arterial events across several heritable connective tissue disorders found that people with COL3A1 mutations had the highest rate of arterial complications, around 21 percent, and experienced those events earlier in life compared with people carrying mutations linked to Marfan syndrome or Loeys-Dietz syndrome.9Journal of the American College of Cardiology. Differences in Arterial Events in Vascular Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome These events can happen in the carotid arteries supplying the brain, the renal arteries, the iliac arteries in the pelvis, and many other locations.
Bowel Perforation
Spontaneous perforation of the colon, most often the sigmoid colon, is a well-recognized complication. A 17-year retrospective study found that bowel perforation and intra-abdominal organ rupture were common events in vEDS patients tracked over time.10PubMed. Natural history of gastrointestinal manifestations in vascular Ehlers-Danlos syndrome: A 17-year retrospective review These events typically present as sudden, severe abdominal pain and can be life-threatening without emergency surgery. For a young person without other risk factors, a spontaneous bowel perforation should raise suspicion for vEDS.
Uterine Rupture
Pregnancy poses specific and serious risks, discussed in more detail in the pregnancy section below. The uterine wall, rich in type III collagen, can rupture during the later stages of pregnancy or during labor.
How vEDS Is Diagnosed
The gold standard for confirming vEDS is genetic testing that identifies a pathogenic mutation in COL3A1. The UK national diagnostic service uses sequencing techniques to examine the gene and confirm the diagnosis in all cases.11PubMed Central. Diagnosis and management of vascular Ehlers-Danlos syndrome: Experience of the UK national diagnostic service, Sheffield Clinical features alone, while suggestive, are not considered sufficient because the physical signs can overlap with other conditions, and some patients with confirmed mutations look quite ordinary on examination.
The problem is getting to the point where testing is ordered. Because vEDS is rare and the outward features can be absent, many patients first come to medical attention through a catastrophic event like an arterial dissection or bowel perforation. A family history of unexplained sudden death, arterial aneurysms, or bowel perforations at a young age should prompt genetic evaluation. Once a mutation is identified in one family member, cascade testing of relatives becomes straightforward and can be genuinely life-saving, since at-risk relatives can be monitored and counseled before a crisis occurs.
Distinguishing vEDS from Other Heritable Vascular Conditions
Several genetic conditions cause aortic or arterial problems, and telling them apart matters because management strategies differ. Marfan syndrome involves the FBN1 gene and primarily threatens the aortic root. Loeys-Dietz syndrome, caused by mutations in TGF-β signaling pathway genes, also causes widespread arterial disease but has different skeletal features and tends to involve arterial tortuosity (twisting). In a cohort comparison, COL3A1 mutations (vEDS) were linked to a substantially higher prevalence of arterial events than the mutations causing Marfan or Loeys-Dietz syndromes, and those events tended to happen at younger ages.12Journal of the American College of Cardiology. Differences in Arterial Events in Vascular Ehlers-Danlos, Loeys-Dietz, and Marfan Syndrome The bowel and uterine complications seen in vEDS are not typical of Marfan or Loeys-Dietz, which provides another clinical clue.
Treatment and Risk Reduction
There is no cure for vEDS, and there is no way to repair the underlying collagen defect with current technology. Treatment focuses on reducing the risk of arterial and organ complications. The best evidence for a specific medication comes from a trial of celiprolol, a beta-blocker with some vasodilatory properties. In that trial, vascular or organ rupture occurred in about 20 percent of patients taking celiprolol, compared with 50 percent in the control group, a meaningful reduction.13PubMed. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial Celiprolol is not universally available in every country, and the trial was modest in size, so clinicians sometimes use other blood-pressure-lowering medications guided by the same principle: reduce mechanical stress on fragile arterial walls.
Beyond medication, lifestyle counseling is a cornerstone of care. Patients are generally advised to avoid contact sports, heavy weight-lifting, and activities that could cause sudden spikes in blood pressure. Invasive medical procedures, including routine colonoscopies and arteriograms, carry elevated risk because the tissue is fragile. Even routine blood pressure cuffs need careful use.
Why Surgery Is Complicated
When an arterial dissection or bowel perforation does occur, surgical repair is necessary but comes with a catch. The same tissue fragility that caused the emergency makes surgery extremely difficult. Sutures can tear through vessel walls, and tissue may not hold repairs. Both open surgery and endovascular (catheter-based) approaches carry high complication rates in vEDS patients.14Journal of Vascular Surgery. Arterial complications of vascular Ehlers-Danlos syndrome Surgeons familiar with the condition use gentler techniques and modified approaches, but the risk remains significantly higher than in the general population. This reality underscores why prevention and early monitoring matter so much: every complication avoided is a high-risk surgery avoided.
Pregnancy Risks
Pregnancy in vEDS is a high-stakes situation. A systematic review concluded that women with vEDS face elevated risks of uterine rupture, vascular events, digestive events, and death during pregnancy.15PubMed. Vascular Ehlers-Danlos syndrome and pregnancy: A systematic review A study tracking 76 deliveries in women with confirmed vEDS found that life-threatening complications occurred in about 15 percent of deliveries, including arterial dissection or rupture in roughly 9 percent and uterine rupture in about 3 percent. There were five maternal deaths in those 76 deliveries, a mortality rate of about 6.5 percent. Four of the five deaths were from arterial dissection or rupture.16Genetics in Medicine. Pregnancy-related deaths and complications in women with vascular Ehlers–Danlos syndrome
These numbers make pregnancy counseling an important part of care for women and families with vEDS. Some women choose to avoid pregnancy entirely; others pursue it with close multidisciplinary monitoring at specialized centers. Cesarean delivery introduces its own risks in this population because of tissue fragility and the potential for wound dehiscence. There is no option that eliminates risk, only options that try to manage it as carefully as possible. Preimplantation genetic testing is available for families who wish to have biologically related children without passing on the COL3A1 mutation.
Monitoring and Surveillance
Because arterial events can happen without warning, the question of how and how often to monitor patients comes up immediately after diagnosis. A European expert consensus within the VASCERN rare vascular disease network found that all experts endorse monitoring, but there are no firm evidence-based guidelines specifying how often imaging should be done or which imaging modality to use. Screening intervals and methods differ among centers.17European Journal of Medical Genetics. Surveillance and monitoring in vascular Ehlers-Danlos syndrome in European Reference Network For Rare Vascular Diseases (VASCERN) In practice, many centers perform periodic CT angiography or MR angiography to watch for developing aneurysms or dissections, though the ideal interval and extent of imaging remain debated. The concern is that aggressive interventional imaging like catheter-based angiography itself poses a risk of vascular injury in these patients.
Living with vEDS and Mental Health
The psychological burden of living with a condition that can cause sudden, life-threatening events at any time is substantial. A cross-sectional study of adults with vEDS and Loeys-Dietz syndrome found that only half of the participants were satisfied with their lives overall. Dissatisfaction was especially high regarding work and career, physical health, and sexual life. Severe fatigue and anxiety symptoms were each strongly associated with low overall life satisfaction.18PubMed Central. Adults with Loeys-Dietz syndrome and vascular Ehlers-Danlos syndrome: A cross-sectional study of life satisfaction
Broader EDS research reinforces these findings. In a questionnaire study of people with various EDS types, about three-quarters scored high for anxiety, and health-related quality of life was significantly lower than in the general population across every domain measured.19PubMed Central. Self-reported quality of life, anxiety and depression in individuals with Ehlers-Danlos syndrome (EDS): a questionnaire study For vEDS specifically, the constant awareness that an emergency could happen at any moment creates a unique layer of health anxiety that differs from chronic pain conditions. Psychological support, including therapy tailored to living with unpredictable medical crises, is increasingly recognized as a necessary part of comprehensive vEDS care rather than an optional add-on.
Gene Therapy and Future Directions
The one treatment that could fundamentally change vEDS would be one that fixes or silences the defective COL3A1 gene. This is not yet possible in patients, but research is moving in that direction. RNA interference technology has been used successfully in laboratory settings to selectively silence the mutant copy of COL3A1 while preserving the healthy copy. In patient-derived skin cells, this approach improved collagen fibril formation and reduced the harmful effects of misfolded proteins.20PubMed Central. Current Evidence and Future Perspectives in the Medical Management of Vascular Ehlers–Danlos Syndrome: Focus on Vascular Prevention Translating a result in skin cells to a therapy that can reach every blood vessel and organ wall in a living person is a massive leap, and no human trials exist yet. But the principle has been demonstrated: if you can shut down the bad copy of the gene, the remaining good copy can produce enough normal collagen to significantly improve tissue integrity. For a disease where even a modest improvement in collagen quality could prevent arterial rupture, that is a meaningful finding.
Other research threads are exploring whether drugs that stabilize the extracellular matrix or reduce inflammation in vessel walls might add to the protective effect of blood-pressure management. The rarity of vEDS makes clinical trials inherently difficult to run. International registries and collaborative research networks like VASCERN are trying to pool enough patients to generate the kind of evidence that has been hard to gather for such an uncommon condition.